Traditonally, clinicians have looked to antifungal drugs to help combat the ever-increasing incidence of fungal diseases. In this article, Cutler, Deepe and Klein discuss the evidence to support their view that antifungal vaccines are now a viable alternative strategy for the prevention of various fungal diseases that should be actively pursued by researchers.
- Jim E. Cutler
- George S. Deepe Jr
- Bruce S. Klein
